Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia.

Autor: AlRuthia Y; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh, 11451, Saudi Arabia. Yazeed@ksu.edu.sa.; Pharmacoeconomics Research Unit, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh, 11451, Saudi Arabia. Yazeed@ksu.edu.sa., Alfakhri AH; Department of Pharmacy, King Saud University Medical City, P.O. Box 3145, Riyadh, 12372, Saudi Arabia., Alharbi I; Pharmacoeconomics Center, Department of Pharmacy, King Fahd Armed Forces Hospital, Jeddah, 23311, Saudi Arabia., Alghamdi FA; Department of Dermatology, King Fahd Armed Forces Hospital, Jeddah, 23311, Saudi Arabia., Alanazi MA; Department of Pharmacy, King Saud University Medical City, P.O. Box 3145, Riyadh, 12372, Saudi Arabia., Alrabiah AA; College of Medicine, King Saud University, Riyadh, 12372, Saudi Arabia., Alsouan AA; College of Medicine, King Saud University, Riyadh, 12372, Saudi Arabia., Alshaikh AA; College of Medicine, King Saud University, Riyadh, 12372, Saudi Arabia., Almasaoud MA; College of Medicine, King Saud University, Riyadh, 12372, Saudi Arabia.

Publikováno v: Cost effectiveness and resource allocation : C/E [Cost Eff Resour Alloc] 2023 Dec 09; Vol. 21 (1), pp. 95. Date of Electronic Publication: 2023 Dec 09.